Skip to main content
Log in

Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial

  • Knee
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Purpose

The present study was designed to evaluate the penetration of diclofenac sodium 4 % spray gel in synovial tissue, synovial fluid and blood plasma after topical application in subjects with joint effusions and planned total knee arthroplasty (TKA) due to osteoarthritis.

Methods

A total of 39 patients were randomised to two- or three-times daily application of diclofenac sodium 4 % spray gel to knees requiring surgery over a treatment period of 3 days. Within 8 h after the last application, TKA was conducted, and the diclofenac concentrations in synovial tissue, synovial fluid and blood plasma were measured by liquid chromatography.

Results

The median diclofenac concentration was approximately 10–20-fold higher in synovial tissue (36.2 and 42.8 ng/g) than in synovial fluid (2.6 and 2.8 ng/mL) or plasma (3.9 and 4.1 ng/mL) in both treatment groups. Dose proportionality for any compartment or treatment groups could not be detected. Treatment-related adverse events were noted in two cases and limited to skin reactions.

Conclusion

Diclofenac sodium 4 % spray gel was found to penetrate the skin locally in substantial amounts and thus reach the desired target tissue. Concentrations were not dose-dependent, and application was well tolerated by 97.4 % of patients. Topical application of diclofenac should be considered a valuable alternative to systemic NSAID therapy in the initial treatment of osteoarthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Arcangeli P, Andreotti L, Palazzini E (1996) Effective treatment of osteoarthritis with a 150 mg prolonged-release of diclofenac sodium. Riv Eur Sci Med Farmacol 18(5–6):217–223

    CAS  PubMed  Google Scholar 

  2. Barron MC, Rubin BR (2007) Managing osteoarthritic knee pain. J Am Osteopath Assoc 107(10 Suppl 6):21–27

    Google Scholar 

  3. Benson MD, Aldo-Benson M, Brandt KD (1985) Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis. Semin Arthritis Rheum 15(2 Suppl 1):65–67

    Article  CAS  PubMed  Google Scholar 

  4. Brune K (2007) Persistence of NSAIDs at effect sites and rapid disappearance from side effect compartments contributes to tolerability. Curr Med Res Opin 23(12):2985–2995

    Article  CAS  PubMed  Google Scholar 

  5. Brunner M, Dehghanyar P, Seigfried B, Martin W, Menke G, Muller M (2005) Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol 60(5):573–577

    Article  CAS  PubMed  Google Scholar 

  6. Courtney P, Doherty M (2002) Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis 61(9):767–773

    Article  CAS  PubMed  Google Scholar 

  7. Davies NM, Anderson KE (1997) Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 33(3):184–213

    Article  CAS  PubMed  Google Scholar 

  8. Elmquist WF, Chan KK, Sawchuk RJ (1994) Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Pharm Res 11(12):1689–1697

    Article  CAS  PubMed  Google Scholar 

  9. Escribano E, Calpena AC, Queralt J, Obach R, Domenech J (2003) Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 19(4):203–210

    Article  CAS  PubMed  Google Scholar 

  10. Felson DT, Neogi T (2004) Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum 50(2):341–344

    Article  PubMed  Google Scholar 

  11. Fowler PD, Shadforth MF, Crook PR, John VA (1983) Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur J Clin Pharmacol 25(3):389–394

    Article  CAS  PubMed  Google Scholar 

  12. Hamad M, Metwally S, El-Shafey A, Geneidi A (1994) Comparative percutaneous absorption of diclofenac emulgel penetrations in normal volunteers. J Drug Res 21:133–141

    Google Scholar 

  13. Henry D, Lim LL, Rodriguez LAG, Gutthann SP, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312(7046):1563–1566

    Article  CAS  PubMed  Google Scholar 

  14. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145–1155

    Article  CAS  PubMed  Google Scholar 

  15. Liauw HL, Ku E, Brandt KD, Benson MD, Aldo-Benson MA, Waiter SL, Lee W, Chan K, Vyas K (1985) Effects of Voltaren on arachidonic acid metabolism in arthritis patients. Agents Actions Suppl 17:195–199

    Article  CAS  PubMed  Google Scholar 

  16. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ (2004) Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 5:10–18

    Article  PubMed Central  PubMed  Google Scholar 

  17. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ (2004) Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 5:28–35

    Article  PubMed Central  PubMed  Google Scholar 

  18. Miyatake S, Ichiyama H, Kondo E, Yasuda K (2008) Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. BJCP 67(1):125–129

    Google Scholar 

  19. Moore RA (2004) Topical nonsteroidal antiinflammatory drugs are effective in osteoarthritis of the knee. J Rheumatol 31(10):1893–1895

    PubMed  Google Scholar 

  20. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316(7128):333–338

    Article  CAS  PubMed  Google Scholar 

  21. Nishihata T, Kotera K, Nakano Y, Yamazaki M (1987) Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. Chem Pharm Bull (Tokyo) 35(9):3807–3812

    Article  CAS  Google Scholar 

  22. Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frolich JC (1991) Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 31(5):537–541

    Article  CAS  PubMed  Google Scholar 

  23. Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M (1986) The percutaneous absorption of diclofenac. Arzneimittelforschung 36(7):1092–1096

    CAS  PubMed  Google Scholar 

  24. Sherertz EF, Sloan KB, McTiernan RG (1987) Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J Invest Dermatol 89(2):147–151

    Article  CAS  PubMed  Google Scholar 

  25. Taylor RS, Fotopoulos G, Maibach H (2011) Safety profile of topical diclofenac: a meta analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin 27(3):605–622

    Article  CAS  PubMed  Google Scholar 

  26. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dincer F, Dziedzic K, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Maheu E, Martin-Mola E, Pavelka K, Punzi L, Reiter S, Sautner J, Smolen J, Verbruggen G, Zimmermann-Gorska I (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66(3):377–388

    Article  CAS  PubMed  Google Scholar 

  27. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2007) OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthr Cartil 15(9):981–1000

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Kate McFarlane for her support in preparing the manuscript and proofreading.

Conflict of interest

T.E. and M.D.S. are consultants to Smith and Nephew, Endoscopy. The study was supported by MIKA Pharma.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Turgay Efe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Efe, T., Sagnak, E., Roessler, P.P. et al. Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial. Knee Surg Sports Traumatol Arthrosc 22, 345–350 (2014). https://doi.org/10.1007/s00167-013-2408-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-013-2408-0

Keywords

Navigation